21 October 2024
On the 6th of October 2024 Calum, Keir and Sean completed the Lisbon Marathon in aid of Melanoma UK. The three friends…
25 July 2023
Bristol Myers Squibb (NYSE: BMY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency…
6 July 2023
One of our newest Ambassadors is reaching for the skies on July 7th in Cirencester.
18 January 2023
David has already done some fundraising for Melanoma UK and decided a few weeks ago that he would climb Kilimanjaro. Not the…
1 December 2022
After a two-year break, visitors to the event will be treated to a jam-packed day, full of exclusive offers, speakers, competitions, product…
25 November 2022
When CRUK, Prof. Gareth Thomas and a team of researchers announced after a six year study they were making a breakthrough in…
25 May 2022
Melanoma is the most serious form of skin cancer and the fifth most common cancer in the UK, with over 40 cases…
21 May 2022
Shane McCormick – Melanoma UK Ambassador for Outdoor Workers
20 May 2022
Jewson is joining forces with leading cancer charity, Melanoma UK, to help protect builders and its own colleagues from the dangers of…
15 May 2022
Melanoma UK is delighted to announce the launch of a new free skin cancer early diagnosis course for Primary Care Practitioners.
16 June 2021
Shane, previously a landscaper in the construction industry and now a Sales Director for Talasey was diagnosed with melanoma skin cancer on…
12 February 2021
NICE has today (Friday 12 February 2021) issued final draft guidance which recommends the routine use of nivolumab (Opdivo; Bristol-Myers Squibb) as…